These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35480992)

  • 1. High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients.
    Kandarini Y; Mahadita GW; Herawati S; Wibhuti IBR; Widiana IGR; Ayu NP
    Int J Gen Med; 2022; 15():4227-4236. PubMed ID: 35480992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.
    Raji YR; Ajayi SO; Adeoye AM; Amodu O; Tayo BO; Salako BL
    Afr Health Sci; 2022 Mar; 22(1):344-351. PubMed ID: 36032486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.
    Liu ZH; Yu XQ; Yang JW; Jiang AL; Liu BC; Xing CY; Lou JZ; Wang M; Cheng H; Liu J; Fu JZ; Zhang AH; Zhang M; Zhou QL; Yu C; Wang R; Wang L; Chen YQ; Guan TJ; Peng A; Chen N; Hao CM; Cheng XY;
    Curr Med Res Opin; 2018 Aug; 34(8):1491-1500. PubMed ID: 29672176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients
.
    Ganidagli B; Nacar H; Yildiz YS; Dagli H; Erken E; Altunoren O; Gungor O
    Clin Nephrol; 2019 Jan; 91(1):9-16. PubMed ID: 30369401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
    Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease.
    Wang XR; Yuan L; Shi R; Li H; Wang DG; Wu YG
    Ren Fail; 2021 Dec; 43(1):1172-1179. PubMed ID: 34315328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic Kidney Disease 3rd stage - laboratory markers of mineral bone disorder].
    Klimentová A; Ságová I; Prídavková D; Kantárová D; Makovický P; Sadloňová J; Mokáň M
    Vnitr Lek; 2016; 62(6):442-8. PubMed ID: 27485841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease.
    Di Lullo L; Gorini A; Bellasi A; Morrone LF; Rivera R; Russo L; Santoboni A; Russo D
    Clin Kidney J; 2015 Dec; 8(6):732-6. PubMed ID: 26613033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Cross-sectional Study of Osteoporosis and Cardiovascular Calcification in Patients with Chronic Kidney Disease at Different CKD Stages].
    Cai ZY; Hu XF; Chen LQ; Li ZR; Du XG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):334-339. PubMed ID: 33829711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients.
    Moldovan D; Moldovan I; Rusu C; Kacso I; Patiu IM; Gherman-Caprioara M
    Int Urol Nephrol; 2014 Jan; 46(1):121-8. PubMed ID: 23549862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study.
    Etta PK; Sharma RK; Gupta A
    Saudi J Kidney Dis Transpl; 2017; 28(4):874-885. PubMed ID: 28748891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
    Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
    Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.